Sign In

Andreas Storsve

Director Business Development hos Targovax ASA - Immuno-Oncology - PhD

Andreas Berg Storsve is currently associated with DoMore Diagnostics, not Targovax as mentioned in the query. He joined DoMore Diagnostics as a team member on June 1, 2023.1 In his role at DoMore Diagnostics, Storsve has been involved in various activities:

  1. He announced a collaboration between DoMore Diagnostics and Stavanger University Hospital on the Digital Biomarker Histotype Px® on October 19, 2023.2

  2. On February 28, 2024, he shared information about the #eicAccelerator program, describing it as a competitive funding program for European start-ups and SMEs.3

  3. Most recently, on August 7, 2024, Storsve reported that DoMore Diagnostics had been granted a new US patent covering Histotype Px® methods by the USPTO.4

These activities suggest that Andreas Berg Storsve is likely in a business development or leadership role at DoMore Diagnostics, focusing on partnerships, funding opportunities, and intellectual property. However, the specific title of Director Business Development at Targovax is not supported by the available information.

Highlights

Oct 28 · rudpedersen.com
Andreas Berg - Rud Pedersen Public Affairs

Related Questions

What are Andreas Berg Storsve's main responsibilities at Targovax?
How did Andreas Berg Storsve transition from the pharmaceutical industry to business development?
What projects has Andreas Berg Storsve led at DoMore Diagnostics?
What is the significance of the Histotype Px® method in the healthcare industry?
How does Andreas Berg Storsve contribute to digitalization projects in healthcare?
Andreas Storsve
Andreas Storsve, photo 1
Andreas Storsve, photo 2
Add to my network

Location

Oslo, Oslo, Norway